Skip to content

FRPT

NASDAQ

Freshpet Inc

Consumer Staples
Food Products

$58.09

2.0%

Updated Today 3:42 PM ET

Report Card

FRPT at a glance — five pillars scored 0–100 from real filed financials.

Value
Growth
Profitability
0
Health
0
Dividends
0

Overall: Unrated · 0/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.

Key Metrics

Market Cap

$0.00

P/E

Forward P/E (est.)

ROE

Revenue Growth

EPS Growth

Profit Margin

FCF Yield

Debt / Equity

ROIC

5.0%

Interest Coverage

5.37x

Current Ratio

6.18x

Dividend Yield

Implied Growth (rev. DCF)

Rating Score

0/100

Business Overview
Research

Freshpet Inc (FRPT) is a small-cap company in the Food Products industry, part of the Consumer Staples sector of the S&P 500.

In its latest reported year it generated about $1.10B in revenue and $139.14M in net profit.

Our model rates FRPT Unrated (0/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.

Economic Moat

Evidence of durable competitive advantage in the filed financials (10 years of history).

No moat evidenceMoat evidence score: 42/100

The numbers don't show a durable competitive advantage — margins, growth, or returns on capital have been unstable or thin. Great returns are still possible; they just aren't protected.

Gross margin level45/100

38.0% average over the last 3 years

Gross margin stability31/100

±5.5 pts around 41.2% across 10 years

Revenue durability100/100

grew in 9 of the last 9 year-over-year periods

Free-cash-flow consistency0/100

positive in 2 of 10 years

Return on invested capital0/100

5.0% latest fiscal year

A moat can't be proven by numbers alone — this scores the evidence a durable advantage leaves behind (pricing power, consistency, returns on capital), computed the same way for every stock. Pair it with the business overview before concluding anything.

Revenue Growth
Research

4Y CAGR

26.9%

Revenue moved from $129.71M in 2016 to $1.10B in 2025, a 26.8% compound annual growth rate. The most recent year was roughly steady year over year. Slower, mature growth is common for established businesses.

Profitability
0/1 checks passedROIC above 10%

Gross Margin

40.8%

Operating Margin

6.9%

Net Margin

12.6%

ROE

Debt Analysis
Research
2/2 checks passedInterest covered 3×+Short-term bills covered

Total Debt

$1.15M

Net Debt

-$380.23M

Net cash position

Net Debt / EBITDA

-5.02x

Debt / Equity

Leverage: debt-to-equity is n/a, and operating profit covers interest about 5.4x, with a current ratio of 6.2x. Detailed balance-sheet leverage is limited for this name. It carries roughly $1.15M of total debt against $381.38M of cash.

Cash Flow Analysis
Research

Operating CF

$160.56M

Free Cash Flow

$12.38M

FCF Margin

1.1%

In the latest year Freshpet Inc produced about $160.56M of operating cash flow and $12.38M of free cash flow after capital spending. Cash flow is what ultimately pays shareholders, so it is worth tracking over time.

Valuation Analysis
Research
0/1 checks passedTrading below DCF fair value

P/E

P/S

P/B

EV / EBITDA

FRPT trades at n/a trailing earnings. With no positive trailing earnings, value it on sales, cash flow, or growth rather than P/E.

DCF Fair Value (Educational)

A two-stage discounted cash flow on real SEC-filed free cash flow — the intrinsic-value anchor professional analysts triangulate from.

DCF fair value / share

$4.32

Current price

$58.09

-93% · Above fair-value estimate

Starting FCF (latest 10-K)

$12.38M

Growth, years 1–5

4.0%

Fade to terminal, years 6–10

2.5%

Discount rate

9.0%

PV of 10-yr free cash flow$95.66M
PV of terminal value$116.84M
Estimated equity value$212.50M
Shares outstanding49M

Cash flows grow at the stage-1 rate (trailing revenue growth, capped at 20%) for five years, fade to 2.5% by year 10, and continue at that rate forever (Gordon terminal value), all discounted at 9.0%. Small changes in assumptions move the result a lot — treat this as one reference point, not a target price. Educational only, not investment advice.

Metrics vs. Sector Range

Where FRPT sits versus its Consumer Staples sector peers in the S&P 500.

TTM P/E
Forward P/E
P/S ratio
Revenue growth
EPS growth
Gross margin
40.8%Average
Net margin
ROE

Bands show the middle half (25th–75th percentile) of the 48 Consumer Staples companies in the S&P 500 — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.

Sector Peer Comparison

How FRPT stacks up against its Consumer Staples peers — valuation, profitability, and growth versus the sector median.

In the Consumer Staples sector (74 S&P 500 companies), FRPT ranks #59 of 74 by our overall rating.

P/E vs sector

median 22.2x

ROE vs sector

median 18.1%

Growth vs sector

median 3.4%

Sector rank

#59

of 74 by rating

CompanyP/ERev Gr.Rating
FRPTThis stockNot rated
AVONot rated
CALMNot rated
JBSSNot rated
JJSFNot rated
MZTINot rated
PPCNot rated
SENEANot rated
Consumer Staples median22.2x3.4%38/100
Compare side by side

Peers are the closest Consumer Staples companies by sub-industry and size. Sector median is across all 74 S&P 500 names in the sector. Educational, not a recommendation.

5-Year Projection Model

Project revenue → earnings → price. Edit the assumptions to build your own case.

2030 price target (Base Case)

$0.00 $0.00

vs. $58.09 today · expected CAGR -2%8%

Metric20262027202820292030
Revenue$1.19B$1.29B$1.39B$1.50B$1.62B
Net income$154.72M$167.10M$180.47M$194.91M$210.50M
EPS$3.15$3.40$3.67$3.97$4.28
Share price (low)$37.78$40.80$44.07$47.59$51.40
Share price (high)$62.97$68.01$73.45$79.32$85.67
CAGR (low–high)-35% / 8%-16% / 8%-9% / 8%-5% / 8%-2% / 8%

Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.

Bull Case

The case for FRPT:

  • As an established S&P 500 member in Consumer Staples, it brings scale and a long operating history.
Bear Case

The case against FRPT:

  • Like any single stock, it is exposed to competition, the economic cycle, and shifts in its end markets.
Key Risks
Research

Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.

Investment Thesis
Research

On balance, the picture is mixed: Freshpet Inc is a small-cap consumer staples business growing at a mature pace, with modest profitability, and a heavier debt load to watch. It trades at n/a earnings, which our model scores Unrated (0/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.

Analyst Ratings

What 23 Wall Street analysts covering FRPT recommend (July 2026). Consensus is a useful sanity check — not a substitute for your own homework.

Buy
consensus · score 4.0 / 5 across 23 analysts
Strong Buy 7Buy 11Hold 4Sell 1Strong Sell 0

Analysts have turned more positive over the last three months (+9 pts of buy ratings).

Latest SEC Filings

FRPT's most recent filings, straight from SEC EDGAR. Annual and quarterly reports are the deep dives; 8-Ks flag material events the moment they happen.

FRPT — frequently asked questions

Is FRPT a good stock to buy?

We don't give buy or sell advice. Review Freshpet Inc's fundamentals, valuation, and 5-year financials on this page, then make your own decision — and consider a licensed professional.

Where does FRPT's data come from?

Live price data plus real fundamentals and 5-year financials pulled directly from Freshpet Inc's SEC filings — refreshed automatically, not hand-entered.

How is the 5-year projection for FRPT calculated?

It's a scenario model: it grows revenue at an assumed rate, applies a profit margin and a valuation multiple, and shows the resulting share-price range. The assumptions are yours to change — it's a tool for thinking, not a prediction.

Is this FRPT analysis financial advice?

No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell FRPT. Always do your own research and consider a licensed professional.

Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.

Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.